Related Experiment Videos
Macrophage cell line B6MP102 resembles peritoneal macrophages in tumor cell recognition and killing
S K Chapes1, E S Didier, W A Tompkins
1Division of Biology, Kansas State University, Manhattan 66502.
Abstract:
In this paper we describe the bone marrow-derived macrophage cell line B6MP102. We describe growth characteristics, responsiveness to biological response modifiers known to activate macrophages (MPs), and the ability of B6MP102--comparable to that of peritoneal MPs--to kill and discriminate tumor cells. We demonstrate that B6MP102 is easily maintained in culture in the presence of 15% L-M cell-conditioned media. We have found that the B6MP102 cell line is similar to in vivo-derived peritoneal MPs. These cells are responsive to biological response modifiers but are not spontaneously cytotoxic. They produce O2- in quantities comparable to that produced by peritoneal MPs, and they exhibit target ranges for direct killing similar to those of activated peritoneal MPs. In addition, B6MP102 is similar to MPs in mediating cytostasis. These latter two points are especially significant, suggesting that the mechanisms that MPs may use to distinguish and kill tumor cells are retained in the B6MP102 cell line. This makes the cell line a useful tool for studying MP-tumor cell interactions.
Insights
A new bone marrow-derived macrophage cell line, B6MP102, effectively kills and distinguishes tumor cells, mirroring in vivo macrophages. This macrophage cell line offers a valuable tool for studying macrophage-tumor cell interactions.
Area of Science:
- Immunology
- Cell Biology
- Cancer Research
Background:
- Macrophages (MPs) are crucial immune cells involved in tumor surveillance and elimination.
- Developing reliable in vitro models for studying macrophage-tumor cell interactions is essential for cancer research.
Purpose of the Study:
- To characterize a novel bone marrow-derived macrophage cell line, B6MP102.
- To evaluate the B6MP102 cell line's responsiveness to biological modifiers and its cytotoxic and cytostatic capabilities against tumor cells.
- To assess the utility of B6MP102 as a model for studying macrophage-mediated anti-tumor mechanisms.
Main Methods:
- Establishment and maintenance of the B6MP102 macrophage cell line in culture.
- Assessment of B6MP102 responsiveness to biological response modifiers.
- Evaluation of B6MP102 cytotoxic and cytostatic activity against tumor cells.
- Comparison of B6MP102 functional characteristics with in vivo-derived peritoneal macrophages.
Main Results:
- The B6MP102 cell line is easily cultured and maintained with standard media.
- B6MP102 cells exhibit responsiveness to biological response modifiers, similar to peritoneal MPs.
- B6MP102 cells demonstrate comparable tumor cell killing and discrimination abilities to activated peritoneal MPs.
- The cell line produces superoxide anion (O2-) and mediates cytostasis, indicating retained anti-tumor mechanisms.
Conclusions:
- The B6MP102 cell line serves as a valuable in vitro model that mimics key functions of in vivo-derived macrophages.
- This macrophage cell line retains the mechanisms for distinguishing and killing tumor cells, making it useful for studying MP-tumor cell interactions.
- B6MP102 provides a consistent and accessible tool for advancing research in cancer immunology and macrophage biology.